Successful treatment of adult‐onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis

Octreotide may be useful in noninsulinoma pancreatogenous hypoglycemia syndrome with nesidioblastosis patients who was on hemodialysis. Continuous octreotide subcutaneous infusion can reduce side‐effects and stabilize plasma glucose levels.

Detalles Bibliográficos
Autores principales: Kato, Rina, Nishimura, Akihiro, Matsumura, Kimio, Kikuno, Shota, Nagasawa, Kaoru, Mori, Yasumichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813030/
https://www.ncbi.nlm.nih.gov/pubmed/33489173
http://dx.doi.org/10.1002/ccr3.3514
_version_ 1783637777424842752
author Kato, Rina
Nishimura, Akihiro
Matsumura, Kimio
Kikuno, Shota
Nagasawa, Kaoru
Mori, Yasumichi
author_facet Kato, Rina
Nishimura, Akihiro
Matsumura, Kimio
Kikuno, Shota
Nagasawa, Kaoru
Mori, Yasumichi
author_sort Kato, Rina
collection PubMed
description Octreotide may be useful in noninsulinoma pancreatogenous hypoglycemia syndrome with nesidioblastosis patients who was on hemodialysis. Continuous octreotide subcutaneous infusion can reduce side‐effects and stabilize plasma glucose levels.
format Online
Article
Text
id pubmed-7813030
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78130302021-01-22 Successful treatment of adult‐onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis Kato, Rina Nishimura, Akihiro Matsumura, Kimio Kikuno, Shota Nagasawa, Kaoru Mori, Yasumichi Clin Case Rep Case Reports Octreotide may be useful in noninsulinoma pancreatogenous hypoglycemia syndrome with nesidioblastosis patients who was on hemodialysis. Continuous octreotide subcutaneous infusion can reduce side‐effects and stabilize plasma glucose levels. John Wiley and Sons Inc. 2020-11-11 /pmc/articles/PMC7813030/ /pubmed/33489173 http://dx.doi.org/10.1002/ccr3.3514 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Kato, Rina
Nishimura, Akihiro
Matsumura, Kimio
Kikuno, Shota
Nagasawa, Kaoru
Mori, Yasumichi
Successful treatment of adult‐onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis
title Successful treatment of adult‐onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis
title_full Successful treatment of adult‐onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis
title_fullStr Successful treatment of adult‐onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis
title_full_unstemmed Successful treatment of adult‐onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis
title_short Successful treatment of adult‐onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis
title_sort successful treatment of adult‐onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813030/
https://www.ncbi.nlm.nih.gov/pubmed/33489173
http://dx.doi.org/10.1002/ccr3.3514
work_keys_str_mv AT katorina successfultreatmentofadultonsetnesidioblastosisbycontinuoussubcutaneousoctreotideinfusioninapatientonhemodialysis
AT nishimuraakihiro successfultreatmentofadultonsetnesidioblastosisbycontinuoussubcutaneousoctreotideinfusioninapatientonhemodialysis
AT matsumurakimio successfultreatmentofadultonsetnesidioblastosisbycontinuoussubcutaneousoctreotideinfusioninapatientonhemodialysis
AT kikunoshota successfultreatmentofadultonsetnesidioblastosisbycontinuoussubcutaneousoctreotideinfusioninapatientonhemodialysis
AT nagasawakaoru successfultreatmentofadultonsetnesidioblastosisbycontinuoussubcutaneousoctreotideinfusioninapatientonhemodialysis
AT moriyasumichi successfultreatmentofadultonsetnesidioblastosisbycontinuoussubcutaneousoctreotideinfusioninapatientonhemodialysis

Ejemplares similares